The Latest Breaking News from Becton, Dickinson, and Company

Becton, Dickinson and Company is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.

The medical devices industry is on the verge of an incoming boom, fueled by its growing demand and technological advancements. In this evolving landscape, investors could scoop up shares of robust medical device stocks Alcon (ALC), Becton, Dickinson (BDX), and Abbott (ABT) for solid gains. Read more….

Discover three Dividend Aristocrats poised for dividend growth and long-term returns.

Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects.

While Becton, Dickinson, and Company has failed to surpass the broader market over the past year, Wall Street analysts are highly bullish on the stock’s prospects.

These quality companies all have something in common: They are trading a little off their 52-week lows and pay an ever-increasing dividend.

These three dividend stocks are fairly priced and could be on their way up.

Picking up undervalued dividend stocks rewards investors with income and potential capital appreciation.

Now is a perfect opportunity to pick up these quality companies trading around their 52-week lows - before they rebound.

Becton Dickinson & Co. (BDX) is expected to report steady growth for its fiscal fourth quarter ended September 2023, scheduled to be released on November 9. While the stock is witnessing weakness over the past month, will the quarterly report be able to spur a rally? Read on.

Despite a decline in inflation in July, persistent concerns over a potential recession could keep the market volatile in the upcoming months. Therefore, it could be wise to invest in dividend stocks AbbVie (ABBV), Emerson Electric (EMR), and Becton Dickinson (BDX) to navigate the market volatility with solid passive income.…